RWM
IRWD icon

Raffa Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Raffa Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38
Closed -$496 – 1135
2021
Q3 		$496 Buy
38
+32
+533% +$414 ﹤0.01% 1049
2021
Q2 		$77 Hold
6
– – ﹤0.01% 1091
2021
Q1 		$67 Buy
+6
New +$63 ﹤0.01% 1096

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Raffa Wealth Management's IRWD Position: Q4 2021 in Review

Raffa Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 38 shares — an estimated $496 sold.

Raffa Wealth Management first reported a position in IRWD in Q1 2021 and held it in 3 quarters. The position peaked at $496 in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Raffa Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Raffa Wealth Management sold 38 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $496.
  • Raffa Wealth Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Raffa Wealth Management's Ironwood Pharmaceuticals position peaked at $496 in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Raffa Wealth Management's 13F filing for Q4 2021, filed 27 Jul 2026.